Una predicción generalizable transcontinental del carcinoma de células escamosas esofágicas utilizando el microbioma...

Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and limited tools for early detection. Saliva is easily accessible and its microbiome composition can serve as a marker for upper gastrointestinal tract disease. This study aims to evaluate the potential of an oral microbiome signature for classifying ESCC.

In a cross-sectional study of 48 ESCC patients and 110 controls from South Africa, a region with high ESCC incidence, we studied the potential utility of an oral microbiome signature for the disease. We built models using nested cross-validation to evaluate whether this signature is generalizable to held-out samples and further evaluated generalizability in studies from China, a distinct geographic region.

We find significant alterations in the oral microbiome in patients with ESCC including significantly reduced α diversity and increased abundance of Fusobacterium nucleatum. We also find that logistic regression models based on microbiome data can better classify ESCC in held-out samples (auROC=0.96) compared to clinical and demographic data (auROC = 0.69; DeLong p < 1 x 10^-8). Lastly, we find that microbiome-based models trained across multiple studies can generalize well to geographically distinct studies.

Our results show that the oral microbiome in individuals with ESCC is distinct from controls and that this signal can generalize across unseen samples, suggesting the potential of saliva to serve as a non-invasive screening tool for ESCC.